{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:16:15Z","timestamp":1793196975567,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.seizure.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T13:15:12Z","timestamp":1452086112000},"page":"41-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":181,"special_numbering":"C","title":["CBD-enriched medical cannabis for intractable pediatric epilepsy"],"prefix":"10.1016","volume":"35","author":[{"given":"Michal","family":"Tzadok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimrit","family":"Uliel-Siboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Linder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orna","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shay","family":"Menascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Nissenkorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Bar","family":"Yosef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Granot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Lerman-Sagie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruria","family":"Ben-Zeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.seizure.2016.01.004_bib0135","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.seizure.2016.01.004_bib0140","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal of the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2016.01.004_bib0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1468-1331.2006.01215.x","article-title":"Diagnosing refractory epilepsy: response to sequential treatment schedules","volume":"13","author":"Mohanraj","year":"2006","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.seizure.2016.01.004_bib0150","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.tins.2011.03.003","article-title":"Supply and demand for endocannabinoids","volume":"34","author":"Alger","year":"2011","journal-title":"Trends Neurosci"},{"issue":"6","key":"10.1016\/j.seizure.2016.01.004_bib0155","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2016.01.004_bib0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.yebeh.2014.08.135","article-title":"Cannabis, cannabidiol, and epilepsy--from receptors to clinical response","volume":"41","author":"Szaflarski","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.seizure.2016.01.004_bib0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.seizure.2016.01.004_bib0170","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.seizure.2016.01.004_bib0175","series-title":"Epilepsy: its symptoms, treatment, and relation to other chronic convulsive diseases","first-page":"321","author":"Reynolds","year":"1861"},{"key":"10.1016\/j.seizure.2016.01.004_bib0180","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.1975.03260160054015","article-title":"Anticonvulsant nature of marijuana smoking","volume":"234","author":"Consroe","year":"1975","journal-title":"JAMA"},{"key":"10.1016\/j.seizure.2016.01.004_bib0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/oxfordjournals.aje.a115642","article-title":"Illicit drug use and the risk of new-onset seizures","volume":"132","author":"Ng","year":"1990","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.seizure.2016.01.004_bib0190","first-page":"176","article-title":"Marijuana use and the risk of new onset seizures","volume":"103","author":"Brust","year":"1992","journal-title":"Trans Amer Clin Climatol Assoc"},{"key":"10.1016\/j.seizure.2016.01.004_bib0195","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1212\/01.WNL.0000127623.03766.75","article-title":"Marijuana use and epilepsy: prevalence in patients of a tertiary care center","volume":"62","author":"Gross","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.seizure.2016.01.004_bib0200","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1124\/jpet.109.159145","article-title":"Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo","volume":"332","author":"Jones","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.seizure.2016.01.004_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2013.03.009","article-title":"The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice","volume":"28","author":"Shirazi-zand","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2016.01.004_bib0210","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/bph.12321","article-title":"Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism","volume":"170","author":"Hill","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.seizure.2016.01.004_bib0215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3565(25)30824-4","article-title":"Cannabidiol\u2013antiepileptic drug comparisons and interactions in experimentally induced seizures in rats","volume":"201","author":"Consroe","year":"1977","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.seizure.2016.01.004_bib0220","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF00450585","article-title":"Toward drugs derived from cannabis","volume":"65","author":"Mechoulam","year":"1978","journal-title":"Naturwissenschaften"},{"issue":"3","key":"10.1016\/j.seizure.2016.01.004_bib0225","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000137430","article-title":"Chronic administration of cannabidiol to healthy volunteers and epileptic patients","volume":"21","author":"Cunha","year":"1980","journal-title":"Pharmacology"},{"issue":"1","key":"10.1016\/j.seizure.2016.01.004_bib0230","first-page":"14","article-title":"Anticonvulsant effect of cannabidiol","volume":"69","author":"Ames","year":"1986","journal-title":"S Afr Med J"},{"key":"10.1016\/j.seizure.2016.01.004_bib0235","series-title":"Marijuana \u201890 International Conference on Cannabis and Cannabinoids; 1990 July 8\u201311; Kolympari, Crete","article-title":"Double-blind clinical study of cannabidiol as a secondary anticonvulsant","author":"Trembly","year":"1990"},{"key":"10.1016\/j.seizure.2016.01.004_bib0240","unstructured":"Cannabinoids for epilepsy (Review) Copyright \u00a9. The Cochrane Collaboration. Published by John Wiley & Sons, Ltd; 2012."},{"issue":"16","key":"10.1016\/j.seizure.2016.01.004_bib0245","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJMp1000695","article-title":"Medical marijuana and the law","volume":"362","author":"Hoffman","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.seizure.2016.01.004_bib0250","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.yebeh.2013.08.037","article-title":"Report of parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy","volume":"29","author":"Porter","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2016.01.004_bib0255","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.yebeh.2015.02.043","article-title":"Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy","volume":"45","author":"Press","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2016.01.004_bib0260","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yebeh.2015.04.009","article-title":"Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: a potential role for infantile spasms and Lennox\u2013Gastaut syndrome","volume":"47","author":"Hussain","year":"2015","journal-title":"Epilepsy Behav"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131116000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131116000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:45:53Z","timestamp":1761011153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131116000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":26,"alternative-id":["S1059131116000054"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2016.01.004","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CBD-enriched medical cannabis for intractable pediatric epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}